Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma

28 Mar 2024

Abstract excerpt

Importance: Determining the impact of germline cancer-predisposition variants (CPVs) on outcomes could inform novel approaches to testing and treating children with rhabdomyosarcoma. Objective: To assess whether CPVs are associated with outcome among children with rhabdomyosarcoma. Design, Setting, and Participants: In this cohort study, data were obtained for individuals, aged 0.01-23.23 years, newly diagnosed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromatin Remodeling and Cancer
Share to Genetic factors in colorectal cancer
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38546643
DOI: 10.1001/jamanetworkopen.2024.4170

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Germline Genetic Testing and Survival Outcomes Among Children With RhabdomyosarcomaPMID 38546643Read ↗

Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group.Semantic proximity Read ↗

Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and Young Adults With Rhabdomyosarcoma.Semantic proximity Read ↗

A systematic review of the prevalence of pathogenic or likely pathogenic germline variants in individuals with FOXO1 fusion-positive rhabdomyosarcoma.Semantic proximity Read ↗

Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma.Semantic proximity Read ↗

Clinical Impact of Germline Multigene Sequencing in Pediatric Cohorts with a Wide Spectrum of Neoplasms.Semantic proximity Read ↗

Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.Semantic proximity Read ↗

Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish studySemantic proximity Read ↗

Family history of cancer and childhood rhabdomyosarcoma: a report from the Children's Oncology Group and the Utah Population Database.Semantic proximity Read ↗

Genetic Risk for Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer.Semantic proximity Read ↗

Assessment of Cancer Predisposition Syndromes in a National Cohort of Children With a Neoplasm.Semantic proximity Read ↗

Clonality and Evolutionary History of RhabdomyosarcomaSemantic proximity Read ↗

Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.